Resmed Inc header image

Resmed Inc

RMD

Equity

ISIN null / Valor 321632

New York Stock Exchange, Inc (2026-03-27)
USD 220.47-0.91%

Resmed Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

ResMed Inc. is a global leader in the development and provision of innovative healthcare solutions, particularly focusing on the management and treatment of chronic diseases such as sleep apnea, COPD (Chronic Obstructive Pulmonary Disease), and other related conditions. The company distinguishes itself through its integration of digital health technologies and cloud-connected medical devices, which are designed to transform patient care by keeping individuals out of hospitals and enabling them to lead healthier lives. ResMed's offerings extend beyond individual patient care to include comprehensive software platforms aimed at supporting healthcare professionals and caregivers. These platforms facilitate the delivery of effective care in home or chosen care settings, thereby enhancing the quality of life for patients, reducing the burden of chronic diseases, and contributing to the reduction of healthcare costs. Operating in more than 140 countries, ResMed's approach to healthcare innovation emphasizes the importance of accessibility and efficiency in managing chronic health conditions on a global scale.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-0.97%1Y
2.15%3Y
15.5%5Y

Performance

26.0%1Y
32.8%3Y
31.4%5Y

Volatility

Market cap

32118 M

Market cap (USD)

Daily traded volume (Shares)

984,997

Daily traded volume (Shares)

1 day high/low

232.18 / 228.6

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals Inc Ionis Pharmaceuticals Inc Valor: 30877188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.82%USD 72.15
Intra-Cellular Therapies Inc
Intra-Cellular Therapies Inc Intra-Cellular Therapies Inc Valor: 23194616
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 131.87
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-7.98%USD 18.16
GE Healthcare Technologies Inc
GE Healthcare Technologies Inc GE Healthcare Technologies Inc Valor: 123735674
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.23%USD 69.23
Option Care Health Inc
Option Care Health Inc Option Care Health Inc Valor: 52359365
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.73%USD 27.27
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.56%EUR 26.00
Guardant Health Inc
Guardant Health Inc Guardant Health Inc Valor: 43633454
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.96%USD 84.61
Laboratorios Farmaceuticos Rovi, SA
Laboratorios Farmaceuticos Rovi, SA Laboratorios Farmaceuticos Rovi, SA Valor: 3591807
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.57%EUR 78.90
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.10%CHF 312.50
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.17%USD 166.38